(Q50769076)

18 March 2018

title

Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions. (English)

1 reference

18 March 2018

24

Old LJ

1 reference

18 March 2018

author name string

Murphy R

1

1 reference

18 March 2018

Green S

2

1 reference

18 March 2018

Ritter G

3

1 reference

18 March 2018

Cohen L

4

1 reference

18 March 2018

Ryan D

5

1 reference

18 March 2018

Woods W

6

1 reference

18 March 2018

Rubira M

7

1 reference

18 March 2018

Cebon J

8

1 reference

18 March 2018

Davis ID

9

1 reference

18 March 2018

Sjolander A

10

1 reference

18 March 2018

Kypridis A

11

1 reference

18 March 2018

Kalnins H

12

1 reference

18 March 2018

McNamara M

13

1 reference

18 March 2018

Moloney MB

14

1 reference

18 March 2018

Ackland J

15

1 reference

18 March 2018

Cartwright G

16

1 reference

18 March 2018

Rood J

17

1 reference

18 March 2018

Dumsday G

18

1 reference

18 March 2018

Healey K

19

1 reference

18 March 2018

Maher D

20

1 reference

18 March 2018

Maraskovsky E

21

1 reference

18 March 2018

Chen YT

22

1 reference

18 March 2018

Hoffman EW

23

1 reference

18 March 2018

Scott AM

25

1 reference

18 March 2018

publication date

1 January 2005

1 reference

18 March 2018

Preparative Biochemistry and Biotechnology

published in

1 reference

18 March 2018

volume

35

1 reference

18 March 2018

page(s)

119-134

1 reference

18 March 2018

issue

2

1 reference

18 March 2018

Immunology and immunotherapy of human cancer: present concepts and clinical developments

cites work

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Rational approaches to human cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Progress in the development of immunotherapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Anti-idiotype vaccine against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPB-200054732

21 January 2018

Identifiers

DOI

10.1081/PB-200054732

1 reference

18 March 2018

PubMed ID

15881594

1 reference

18 March 2018